HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

2nd Edition of

International Ophthalmology Conference

October 19-21, 2023 | Boston, Massachusetts, USA

Ophthalmic Manifestations of Coronavirus

Ophthalmic Manifestations of Coronavirus

The global pandemic caused by the coronavirus has had far-reaching and long-lasting impacts. The disease's entire breadth has yet to be discovered. Initially, there were multiple anecdotal and published reports of eye redness and irritation in COVID-19 patients, implying that conjunctivitis is an ocular symptom of SARS-CoV-2 infection. COVID-19 has been linked to uveitic, retinovascular, and neuro-ophthalmic illness, according to new research. Based on the findings in the patients' eyes, it's been indicated that unprotected eyes can also become infected with the SAR-CoV-2 virus. The drugs used to treat COVID-19 have ocular side effects as well. Although long-term treatment of chloroquine and hydroxychloroquine can cause retinal damage, this is neither expected or seen with COVID-19.

  • Follicular Conjunctivitis
  • Central Retinal Vein Occlusion
  • Central Retinal Artery Occlusion
  • Mucormycosis
  • Optic Neuritis
  • Cranial Nerve Palsy
  • Medications Leading to Ocular Toxicity
Committee Members
Speaker at International Ophthalmology Conference 2023 - Jeffrey Freedman

Jeffrey Freedman

Professor Emeritus SUNY Brooklyn, United States
Speaker at International Ophthalmology Conference 2023 - Sibylle Scholtz

Sibylle Scholtz

Institute of Experimental Ophthalmology, Germany
Speaker at International Ophthalmology Conference 2023 - Gowhar Ahmad

Gowhar Ahmad

Florence Hospital multi-speciality center chanapora Srinagar Kashmir, India

Submit your abstract Today